NCT05530291View on ClinicalTrials.gov

Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database Analysis

CompletedOBSERVATIONAL
Enrollment

85,259

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

November 22, 2022

Study Completion Date

November 22, 2022

Conditions
Chronic Kidney Disease
Interventions
OTHER

Non-interventional

Epidemiology of anemia associated with chronic kidney disease, rather than to evaluate specific drugs

Trial Locations (1)

61352

Site DE49001, Bad Homburg

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY